MedTrace Logo

Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements

NCT07630584 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 327

Last updated 2026-06-05

No results posted yet for this study

Summary

This is a double-blind, randomized, placebo-controlled nutritional study aimed at investigating growth, tolerance, and functional biomarkers in healthy infants receiving dietary supplements from birth to 2.5 months of age

Conditions

  • Healthy Infants

Interventions

DIETARY_SUPPLEMENT

Probiotic dietary supplement

Probiotic dietary supplement administered once per day

DIETARY_SUPPLEMENT

Placebo dietary supplement

Placebo dietary supplement administered once per day

Sponsors & Collaborators

  • University of the East Ramon Magsaysay Memorial Medical Center, Inc, Philippines

    collaborator UNKNOWN

  • Asian Hospital and Medical Center, Muntinlupa, Philippines

    collaborator UNKNOWN

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Dr Edison Alberto

  • Dr Vinna Marie Quinones · University of East Ramon Magsaysay Memorial Medical center, Philippines

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
14 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-01-31
Completion
2028-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630584 on ClinicalTrials.gov